To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Activist shareholder attempts to scupper AMO Bausch & Lomb bid(2)
Warburg Pincus’ bid for Bausch & Lomb looked more likely, as trade buyer Advanced Medical Optics’ third largest shareholder ValueAct Capital criticised the risk involved in the healthcare company’s higher counter bid.
